Relation between time from myocardial infarction to enrolment and patient outcomes in the Multicenter UnSustained Tachycardia Trial.
OBJECTIVE
We sought to assess the relation between time from myocardial infarction (MI) to enrolment and patient outcomes and to examine the association between these outcomes and implantable cardioverter defibrillator (ICD) therapy.


RESULTS
We analysed the Multicenter UnSustained Tachycardia Trial database (n = 1650). In examining all endpoints, Cox proportional hazards models were used to adjust for potential confounders. There was no significant association between time from MI to enrolment and any of the outcomes (P > 0.1). Inducibility by an electrophysiology study (EPS) was associated with a higher risk of arrhythmic death or cardiac arrest [adjusted hazard ratio (HR) 2.51; 95% confidence interval (CI) 1.64-3.84] and all-cause death (adjusted HR 1.45; 95% CI 1.04-2.03) only in patients who had an MI <or=6 months prior to enrolment. ICD therapy was associated with improved survival in patients who had an MI <or=6 months (adjusted HR 0.35; 95% CI 0.17-0.74) and >6 months before enrolment (adjusted HR 0.34; 95% CI 0.21-0.54).


CONCLUSIONS
The risk of arrhythmic death or cardiac arrest and all-cause death did not vary as a function of time from the most recent MI to enrolment. Inducibility by an EPS was associated with worse outcomes only in patients with an MI <or=6 months prior to enrolment. Although ICD therapy was associated with improved survival regardless of the time from MI to enrolment, this finding needs to be verified by a randomized clinical trial.
Al-Khatib
Sana M
SM
1 Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA.
Hafley
Gail
G
Lee
Kerry L
KL
Buxton
Alfred E
AE
D000368:Aged; D016208:Databases, Factual / Q000706:statistics & numerical data; D016757:Death, Sudden, Cardiac / Q000453:epidemiology / Q000517:prevention & control; D017147:Defibrillators, Implantable / Q000706:statistics & numerical data*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic / Q000706:statistics & numerical data; D009203:Myocardial Infarction / Q000401:mortality* / Q000628:therapy*; D016016:Proportional Hazards Models; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D012307:Risk Factors; D013610:Tachycardia / Q000401:mortality* / Q000628:therapy*; D016896:Treatment Outcome
J Am Coll Cardiol. 2008 Sep 30;52(14):1111-21
18804736
N Engl J Med. 1996 Dec 26;335(26):1933-40
8960472
J Am Coll Cardiol. 2006 Jan 3;47(1):98-107
16386671
N Engl J Med. 1999 Dec 16;341(25):1882-90
10601507
J Am Coll Cardiol. 2003 Aug 20;42(4):652-8
12932596
N Engl J Med. 2002 Mar 21;346(12):877-83
11907286
Circulation. 2008 May 27;117(21):e350-408
18483207
Circulation. 2004 Mar 9;109(9):1082-4
14993128
N Engl J Med. 2004 Dec 9;351(24):2481-8
15590950
N Engl J Med. 2005 Jun 23;352(25):2581-8
15972864
N Engl J Med. 2009 Oct 8;361(15):1427-36
19812399
N Engl J Med. 2005 Jan 20;352(3):225-37
15659722